Mapp Biopharmaceutical is a biotechnology company that develops pharmaceuticals for the treatment of infectious diseases. It has expertise in the research and development of ZMapp, a drug which is still under development, comprising three humanized monoclonal antibodies as a treatment for Ebola virus disease.